Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta‐analysis of a complex issue
- 20 August 2017
- journal article
- review article
- Published by Wiley in Liver International
- Vol. 38 (3) , 503-514
Abstract
Background & Aims: Hepatocellular carcinoma (HCC) surveillance is associated with improved outcomes and long‐term survival. Our goal is to evaluate adherence rates to HCC surveillance.Methods: We performed a systematic search of the PubMed and Scopus databases and abstract search of relevant studies from recent major liver meetings. All searches and data extraction were performed independently by two authors. Analysis was via random‐effects models and multivariate meta‐regression.Results: A total of 22 studies (n = 19 511) met inclusion criteria (original non‐interventional studies with defined cirrhosis or chronic hepatitis B or chronic hepatitis C with advanced fibrosis populations, and surveillance tests and intervals). Overall adherence rate was 52% (95% CI 38%‐66%). Adherence was significantly higher in cirrhotic patients compared to chronic hepatitis B and other high‐risk patients, in European compared to North American studies, in less than 12‐month compared to yearly surveillance intervals, and in prospective compared to retrospective studies (71%, 95% CI 64%‐78% vs 39%, 95% CI 26%‐51%, P < .001). The between‐study heterogeneity of all above analyses was significant (P < .001). Only the study design (retrospective vs prospective cohort) had statistical significance in a multivariate meta‐regression model (P < .05) and could account for some of the differences above.Conclusions: Overall adherence rate to HCC surveillance was suboptimal at 52% with no significant differences by liver disease aetiology or study location in multivariate meta‐regression analysis. Further research and educational efforts are needed to improve the current rate of HCC surveillance.Keywords
This publication has 46 references indexed in Scilit:
- Effectiveness of Hepatocellular Carcinoma Surveillance in Patients with CirrhosisCancer Epidemiology, Biomarkers & Prevention, 2012
- Hepatocellular carcinoma screening practices and impact on survival among hepatitis B‐infected Asian AmericansJournal of Viral Hepatitis, 2012
- Patient Involvement in Healthcare is Associated With Higher Rates of Surveillance for Hepatocellular CarcinomaJournal of Clinical Gastroenterology, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Use of Surveillance for Hepatocellular Carcinoma Among Patients With Cirrhosis in the United StatesHepatology, 2010
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinomaHepatology International, 2010
- Adherence to Screening for Hepatocellular Carcinoma Among Patients with Cirrhosis or Chronic Hepatitis B in a Community SettingDigestive Diseases and Sciences, 2009
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Randomized controlled trial of screening for hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2004
- Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosisJournal of Hepatology, 1994